The Filing Desk

KORU Medical Systems vs Myomo

KORU Medical Systems KRMD · Myomo MYO · Health Care Equipment

KORU Medical Systems reported revenue of $41 million in fiscal 2025, about the same as Myomo's $41 million in fiscal 2025. KORU Medical Systems' revenue grew 22.2% in its latest year, and Myomo's grew 25.7%. KORU Medical Systems had an operating margin of -7.2%, against -35.2% at Myomo. Free cash flow was −$0 million at KORU Medical Systems and −$16 million at Myomo.

Side by side

KORU Medical SystemsMyomo
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$41M$41M
Revenue growth22.2%25.7%
Revenue growth a year, last 5 years11.2%40.0%
Gross margin62.3%65.7%
Operating margin−7.2%−35.2%
Net margin−6.4%−38.0%
Free cash flow−$0M−$16M
Free cash flow margin−1.1%−39.7%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count0.8%10.8%
Last close$3.44$0.84
P/E at the last close——
Insider trades, last 12 monthsbought $241,615, sold $0bought $439,324, sold $102,893
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
KORU Medical SystemsMyomo
Operating margin
Percent of revenue
KORU Medical SystemsMyomo
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
KORU Medical SystemsMyomo

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the KORU Medical Systems and Myomo pages.